The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in sales , its intellectual property lapse created a wave of lower-priced alternatives , significantly diminishing its position . While certain pharmaceutical companies may seek to capitalize on similar